Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now

Visual Acuity clinical trials

2 of 21 indexed Visual Acuity trials are currently recruiting.

Corpus placement: #797 of 28,707 conditions by registered trial count.

21 US clinical trials · 2 currently recruiting · #797 of 28,707 conditions by registered trial count

Visual Acuity: 21 US clinical trials tracked, 2 recruiting.

Visual Acuity is the subject of 21 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. The most active sponsor is Johnson & Johnson Vision Care, running 19 of these trials.

Enrollment posture brief

Registry condition visual-acuity

OPEN 2 | RECR 10% | LATE 0 | EARLY 0 | RANK #797 | SPON 19

Nearest open-share peer: Pulmonary Disease, Chronic Obstructive (9% recruiting · 75 trials)

Anal Cancer42.9%Allergic Conjunctivitis14.3%Visual Acuity (this)10%Attention Deficit Disorder W4.8%Adult Acute Myeloid Leukemia0%
Open-enrollment share among volume-matched conditions near Visual Acuity

Visual Acuity lists 2 open slots (10% of 21 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Visual Acuity on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Visual Acuity is recruiting below its size-band peers.

    2 of 21 indexed trials (9.5%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Visual Acuity research.

    Johnson & Johnson Vision Care accounts for 19 of 21 trials (90.5%). 3 distinct sponsors appear on at least one study for this condition label.

  3. Typical Visual Acuity enrolment sits around 95 participants.

    Median target enrolment is 95 among the 21 trials that report a genuine target (sentinel values excluded). 12 of those (57.1%) plan for fewer than 100 participants.

  4. Visual Acuity research is mostly interventional.

    20 interventional and 1 observational studies make up this index (95.2% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Open and recent trials

21 total, page 1 of 1

RECRUITING 120 participants

Clinical Evaluation of Low Contrast Visual Performance and Low Light Phenomena in Patients With Various Intraocular Lens Implants

Dr. Daniel H. Chang, MD

NCT07213167

RECRUITING NA 36 participants

Evaluation of Effect of Scatter on Visual Performance

Johnson & Johnson Vision Care

NCT07443215

COMPLETED NA 554 participants

Clinical Study of Approved and Investigational Contact Lenses

Johnson & Johnson Vision Care

NCT02708524

COMPLETED NA 344 participants

Clinical Performance of Senofilcon A Investigational Lens

Johnson & Johnson Vision Care

NCT05300763

COMPLETED NA 253 participants

Design Validation of Senofilcon A With New UV-blocking Additive

Johnson & Johnson Vision Care

NCT03707821

COMPLETED NA 228 participants

Evaluation of Prototype Lenses With Experimental UV/HEV Blocker

Johnson & Johnson Vision Care

NCT04885296

COMPLETED NA 174 participants

Clinical Evaluation of Spherical Soft Contact Lenses, Toric Soft Contact Lenses and Spectacles in Low Astigmats

Johnson & Johnson Vision Care

NCT05056870

COMPLETED NA 142 participants

Clinical Evaluation of Approved Contact Lenses

Johnson & Johnson Vision Care

NCT02699593

COMPLETED NA 123 participants

Clinical Evaluation of Senofilcon A Contact Lenses Using a Novel Manufacturing Technology to Evaluate Overall Visual Acuity.

Johnson & Johnson Vision Care

NCT05361304

COMPLETED NA 119 participants

Clinical Evaluation of a Daily Wear Reusable Multifocal Optical Design in a Presbyopic Population

Johnson & Johnson Vision Care

NCT04534517

COMPLETED NA 95 participants

Evaluation of Daily Disposable Silicone Hydrogel Multifocal Toric Contact Lenses

Johnson & Johnson Vision Care

NCT04974697

COMPLETED NA 95 participants

Evaluation of Dryness in a Silicone Hydrogel Daily Disposable Contact Lens

Johnson & Johnson Vision Care

NCT04849780

COMPLETED NA 81 participants

Evaluation of Investigational Daily Disposable Multifocal Contact Lenses Produced With Different Manufacturing Processes in Myopes

Johnson & Johnson Vision Care

NCT04889625

COMPLETED NA 77 participants

Comparison of a Daily Disposable Multifocal Contact Lens to a Marketed Product

Johnson & Johnson Vision Care

NCT05101252

COMPLETED NA 74 participants

Pilot Dispensing Study of Two Marketed Daily Disposable Multifocal Contact Lenses

Johnson & Johnson Vision Care

NCT07076160

COMPLETED NA 71 participants

Clinical Evaluation of a Reusable Multifocal Optical Design in a Presbyopic Population Phase 2

Johnson & Johnson Vision Care

NCT03586648

COMPLETED NA 71 participants

Evaluation of a Daily Disposable Novel Multifocal Contact Lens in a Myopic Population; Part 2

Johnson & Johnson Vision Care

NCT04615507

COMPLETED NA 45 participants

Clinical Evaluation of Manufacturing Processes for a Reusable Multifocal Optical Design in a Presbyopic Population

Johnson & Johnson Vision Care

NCT03787472

COMPLETED NA 40 participants

Role of Glare and Spectral Filtering on Contrast Sensitivity: A Pilot Study

Johnson & Johnson Vision Care

NCT05582304

COMPLETED NA 30 participants

Clinical Assessment of Visual Function With the Acrysof ReSTOR Multifocal IOL

Alcon Research

NCT00759096

COMPLETED 30 participants

Evaluation of a Toric Multifocal Contact Lens Manufactured in Etafilcon Material in a Low ADD Hyperopic Population

Johnson & Johnson Vision Care

NCT03713281

Phase Distribution

Phase data not available

Top Sponsors

Named interventions

Most-linked intervention names on Visual Acuity records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

senofilcon A C3 Device
2 trials
Samfilcon A Contact Lens Device
1 trials
Lotrafilcon B Contact Lens Device
1 trials
Comfilcon A Contact Lens Device
1 trials
Senofilcon C Contact Lens Device
1 trials
JJVC Marketed Contact Lens Device
1 trials
TRP-200 Device
1 trials
ACUVUE OASYS® with HYDRACLEAR® PLUS Device
1 trials

US sites by state

Facility locations filed on Visual Acuity trials. A trial with sites in several states counts in each.

Florida 17 trials
Ohio 14 trials
New York 12 trials
Texas 11 trials
Kansas 7 trials
Georgia 7 trials
Tennessee 6 trials
Rhode Island 6 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Visual Acuity page

21 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Visual Acuity condition card totals 21 registered trials; most-linked intervention senofilcon A C3; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.